Neurologian yksikkö
Department of Neurology

Julkaisut 1997
Publications 1997

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Aejmelaeus R et al. Unidentified antioxidant defences of human plasma in immobilized patients: a possible relation to basic metabolic rate.
2 Aura J et al. Methoctramine moderately improves memory but pirenzepine disrupts performance in delayed non-matching to position test.
3 Bragin A et al. Epileptic afterdischarge in the hippocampal-entorhinal system:current source density and unit studies.
4 Bragin A et al. Termination of epileptic afterdischarge in the hippocampus.
5 Collin P et al. Dementia and coeliac disease.
6 Farrer LA et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease.
7 Heckbert SR et al. The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State examination in older adults.
8 Helisalmi S et al. No association between alfa1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer`s disease.
9 Helisalmi S et al. Lack of association between presenilin-1 polymorphism, Alzheimer's disease and apolipoprotein E.
10 Hänninen T et al. Decline of frontal lobe functions in subjects with age-associated memory impairment.
11 Hänninen T, Soininen H. Age-associated memory impairment Normal aging or warning of dementia?
12 Immonen-Räihä P et al. Trends in case-fatality of stroke in Finland during 1983 to 1992.
13 Jolkkonen J et al. Seizure-induced damage to somatostatin-immunoreactive neurons in the rat hippocampus is regulated by fimbria-fornix transection.
14 Jolkkonen J et al. Cholinergic deafferentation exacerbates seizure-induced loss of somatostatin-immunoreactive neurons in the rat hippocampus.
15 Jäkälä P et al. Fragile-X: Neuropsychological test performance, CGG triplet repeat lengths, and hippocampal volumes.
16 Jäkälä P et al. Activation of acetylcholine receptors and 5-HT2 receptors have additive effects in the suppression of neocortical high-voltage spindles in aged rats.
17 Jäkälä P, Riekkinen P Jr. Combined cholinergic and 5-HT2 receptor activation suppresses thalamocortical oscillations in aged rats.
18 Kaarisalo MM et al. Atrial fibrillation and stroke mortality and causes of death after the first acute ischemic stroke.
19 Korhonen P et al. Age-related changes in the regulation of transcription factor NF-kappaB in rat brain.
20 Korhonen P et al. Glutamate-induced changes in the DNA-binding complexes of transcription factor YY1 in cultured hippocampal and cerebellar granule cells.
21 Kotti T. Excitotoxicity-Induced Neuropathological Changes in the Rodent Hippocampus. Possible Functional Consequences and Drug Treatments.
22 Kotti T et al. Comparison of NADPH diaphorase histochemistry, somatostatin immunohistochemistry, and silver impregnation in detecting structural and functional impairment in experimental status epilepticus.
23 Kotti T et al. Characterization of target cells for aberrant mossy fiber collaterals in the dentate gyrus of epileptic rat.
24 Kuhmonen J et al. Neuroprotective effects of dexmedetomidine in the gebril hippocampus after transient global ischemia.
25 Kuusisto J et al. Association between features of the insulin resistance syndrome and Alzheimer`s disease independently of apolipoprotein E4 phenotype:cross sectional population based study.
26 Kälviäinen R et al. MRI volumetry and T2 relaxometry of the amygdala in newly diagnosed and chronic temporal lobe epilepsy.
27 Laakso MP et al. MRI volumetry of the hippocampus: the effect of slice thickness on volume formation.
28 Lahtinen H et al. Selegiline treatment after transient global ischemia in gerbils enhances the survival of Ca1 pyramidal cells in the hippocampus.
29 Lappalainen K et al. Intracellular distribution of oligonucleotides delivered by cationic liposomes: light and electron microscopic study.
30 Lehtovirta M, Soininen H. Alzheimerin taudin perinnöllisyys.
31 Malandrini A et al. Localization of the laminin alfa2 chain in normal human skeletal muscle and peripheral nerve: an ultrastructural immunolabeling study.
32 Miettinen M et al. Distribution of calretinin-immunoreactivity in the rat entorhinal cortex:coexistence with GABA.
33 Mikkonen M et al. Distribution of parvalbumin-, calretinin-, and calbindin-D28k-immunoreactive neurons and fibers in the human entorhinal cortex.
34 Partanen J et al. Relationship between EEG reactivity and neuropsychological tests in vascular dementia.
35 Pirttilä T et al. Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains.
36 Pussinen R et al. Enhancement of intermediate-term memory by an alpha-1 agonist or a partial agonist at the glycine site of the DMDA receptor.
37 Puumala T et al. Lack of relationship between thalamic oscillations and attention in rats:Differential modulation by an alpha-2 antagonist.
38 Puumala T, Sirviö J. Stimulation and blockade of alpha1 adrenoceptors affect behavioural activity, but not spatial working memory assessed by delayed non-matching to position task in rats.
39 Puurunen K et al. Studies on the influence of enriched-environment housing combined with systemic administration of an alpha2-adrenergic antagonist on spatial learning and hyperactivity after global ischemia in rats.
40 Riekkinen M et al. Effects of stimulation of alpha1-adrenergic and NMDA/glycine-B receptors on learning defects in aged rats.
41 Riekkinen M, Riekkinen P Jr. Nicotine and D-cycloserine enhance acquisition of water maze spatial navigation in aged rats.
42 Riekkinen M, Riekkinen P Jr. Dorsal hippocampal muscarinic acetylcholine and NMDA receptors disrupt water maze navigation.
43 Riekkinen M et al. Effects of combined chronic nimodipine and acute metrifonate treatment on spatial and avoidance behavior.
44 Riekkinen M et al. Subchronic treatment increases the duration of the cognitive enhancement induced by metrifonate.
45 Riekkinen P Jr. Animal models and Alzheimer`s disease.
46 Riekkinen P Jr et al. THA disrupts mismatch negativity in Alzheimer disease.
47 Riekkinen P Jr et al. Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease.
48 Riekkinen P Jr et al. Chronic nimodipine and acute metrifonate treatment decreases age-related cortical high voltage spindles in rats.
49 Riekkinen P Jr et al. Behavioral characterization of metrifonate-improved acquisition of spatial information in medial septum-lesioned rats.
50 Riekkinen P Jr et al. The ability of THA treatment to increase cortical alpha waves is related to apolipoprotein E genotype of Alzheimer disease patients.
51 Riekkinen P Sr. Neurologian tutkimus tänään.
52 Riekkinen PJ Sr, Soininen HS. Apolipoprotein E and temporal lobe pathology: magnetic resonance imaging and population-based studies.
53 Ruotsalainen S. Serotonergic System and its Interactions with Cholinergic Receptor Mediated Mechanisms in the Modulation of Working Memory An Experimental Study.
54 Ruotsalainen S et al. Additive deficits in the choice accuracy of rats in the delayed non-matching to position task after cholinolytics and serotonergic lesions are non-mnemonic in nature.
55 Ruotsalainen S et al. Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks.
56 Salminen A et al. Down-regulation of Ku autoantigen, DNA-dependent protein kinase, and poly(ADP-ribose) polymerase during cellular senescence.
57 Savander V. Organization of Intrinsic Connections in the Rat Amygdaloid Complex.
58 Savander V et al. Interamygdaloid projections of the basal and accessory basal nuclei of the rat amygdaloid complex.
59 Savander V et al. Lateral nucleus of the rat amygdala is reciprocally connected with basal and accessory basal nuclei: a light and electron microscopic study.
60 Shapiro ML et al. Cues that hippocampal place cells encode: dynamic and hierarchical representation of local and distal stimuli.
61 Sivenius J. Lääkehoidon mahdollisuudet aivohalvauksen ehkäisyssä.
62 Sivenius J, Puranen J. Antiplatelet therapy in secondary prevention of stroke.
63 Sivenius J, Riekkinen P Sr. The second European Stroke Prevention Study (ESPS-2).
64 Six J. Cytoskeletal alterations in Alzheimer`s disease: the role of tau phosphorylation.
65 Soininen H. Alzheimerin taudin hoito.
66 Soininen H. Challenge of Alzheimer`s disease is taken in Finland.
67 Sorvari H. Neurons Containing Calcium-Binding Proteins in the Human Amygdaloid Complex.
68 Stroke Unit Trialists` Collaboration. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke.
69 Stroke Unit Trialists` Collaboration. How do stroke units improve patient outcomes.
70 Tanila H et al. Brain aging:changes in the nature of information coding by the hippocampus.
71 Tanila H et al. Discordance of spatial representation in ensembles of hippocampal place cells.
72 Tanila H et al. Brain aging:impaired coding of novel environmental cues.
73 Tapiola T et al. The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer`s disease.
74 Torpström A et al. Tymektomian merkitys myasthenia graviksen hoidossa.
75 Vanhanen M et al. Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function.
76 WHO MONICA Project et al. Stroke trends in the WHO MONICA project.
77 Wittner M et al. Alfa2-adrenoreceptor agonist, dexmedetomidine, alters acute gene expression after global ischemia in gebrils.
78 Wittner M et al. Alfa2-Adrenoreceptor agonist, dexmedetomidine, alters acute gene expression after global ischemia in gerbils.

Neurologian yksikkö Department of Neurology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008